Acceleron Pharma Inc Conference Call to Discuss Overview Of CMT And Review Of Phase 2 Clinical Trial

3/4/2017 11:00

Conference Call Acceleron Pharma Inc

Acceleron Pharma Inc Conference call or earnings call will be held on Apr 3, 2017 During the earnings conference call's session Acceleron Pharma Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Acceleron Pharma Inc for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that are based on the mechanisms that the human body uses to regulate the growth and repair of its cells and tissues. Our research focuses on key natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta, or TGF-beta, protein superfamily. We are a leading company in discovering and developing therapeutic candidates that regulate cellular growth and repair. By combining our discovery and development expertise, including our proprietary knowledge of the TGF-beta superfamily, and our internal protein engineering and manufacturing capabilities, we have built a highly productive discovery and development platform that has generated innovative therapeutic candidates with novel mechanisms of action.    
Read more Conference Call

Acceleron Pharma Inc (XLRN)

128 Sidney Street, Cambridge Massachusetts 02139, United States